2 Value Stocks to Dive Into Now: Aclaris Therapeutics, Inc. (ACRS), Bristol-Myers Squibb Company (BMY) – Post Analyst

This post was originally published on this site

2 Value Stocks to Dive Into Now: Aclaris Therapeutics, Inc. (ACRS), Bristol-Myers Squibb Company (BMY)  Post Analyst

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) is simply too cheap to pass with a price-to-sales ratio of 15.08. The competitors from Biotechnology hold an average …

This post was originally published on *this site*